Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02297542
PHASE4

Immune Response to High-Dose vs. Standard Dose Influenza Vaccine

Sponsor: Health Sciences North Research Institute

View on ClinicalTrials.gov

Summary

This 5-year proposal is a randomized study of split-virus influenza vaccine (SVV) in a high-dose (HD) vs. standard-dose (SD) formulation in each of five influenza seasons to define the key determinants of vaccine-mediated protection against influenza and how these immunologic mediators may be enhanced by vaccination with a newly approved high-dose influenza vaccine in older people

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

393

Start Date

2014-02-01

Completion Date

2026-09-21

Last Updated

2026-10-05

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

Flu Vaccine

Locations (2)

Center on Aging, UConn Health

Farmington, Connecticut, United States

Health Sciences North Research Institute

Greater Sudbury, Ontario, Canada